Anne Li August 6th, 2017
Breast cancer patients who have radiotherapy targeted at the original tumour site experience fewer side effects five years after treatment than those who have whole breast radiotherapy, and their cancer is just as unlikely to return. The Cancer Research UK-funded IMPORT LOW trial revealed that five years after treatment, almost all patients were disease free. The researchers at 30 radiotherapy centres across the UK, led by The Institute of Cancer Research, London, and the Cancer Research UK Cambridge Center, studied more than 2,000 women aged 50 or over who had early stage breast cancer that was at a low risk of coming back.
See original article at: https://www.cancerresearchuk.org/about-us/cancer-news/press-release/2017-08-02-targeted-radiotherapy-limits-side-effects-of-breast-cancer-treatment
